Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Impact of HPV vaccination in Rwanda

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 17.11.17
Views: 1694

Dr Stephen Rulisa - University of Rwanda, Kigali, Rwanda

Dr Rulisa talks to ecancer at AORTIC 2017 about the introduction of the HPV vaccine in Rwanda.

He describes how, through multi-year school-based campaigns and community campaigns, a high rate of vaccination was achieved in Rwanda, the first country in Africa to introduce the human papillomavirus (HPV) vaccine.

Dr Rulisa describes how the campaigns strengthened the health system overall, as other health concerns could be addressed at the same time as vaccination with no long-term burden on the workload of care providers, and looks towards future data on HPV-related cancers being gathered over time.

Related videos

follow us

Biosimilar Medicines Core Principles and Communication

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation